Chronic cough, defined as a cough persisting for over eight weeks, poses a significant challenge to healthcare providers due to its multifactorial etiology and complexity in management. This article provides a comprehensive approach to managing chronic cough in clinical practice.
Understanding the pathophysiology of chronic cough is pivotal in its management. The cough reflex is a protective mechanism primarily involving the upper and lower airways, the cough center in the brain, and the afferent and efferent nerves. Any irritation or inflammation in this pathway can result in a chronic cough.
Identifying the cause of chronic cough requires a thorough clinical evaluation. Common culprits include gastroesophageal reflux disease (GERD), postnasal drip syndrome, and asthma. However, less common causes like lung cancer, interstitial lung diseases, and ACE inhibitor use should also be considered.
Treatment should be directed towards the underlying cause. For instance, proton pump inhibitors may be beneficial in GERD-associated cough, while inhaled corticosteroids can be useful in asthma-related cough. Non-pharmacological interventions such as lifestyle modifications and cough suppression techniques can also play a significant role.
Despite targeted treatment, some patients continue to have a persistent cough. This may be due to a hypersensitive cough reflex or unaddressed comorbid conditions. Future research should focus on novel therapeutic targets and personalized medicine approaches for these refractory cases.
Managing chronic cough is complex and necessitates a thorough understanding of its pathophysiology, a comprehensive diagnostic evaluation, and individualized treatment plans. By adopting a patient-centered approach and staying abreast with the latest research, clinicians can improve the quality of life for patients suffering from this debilitating condition.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation